Coagulation Protein Disorders Clinical Trials

Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +34 more
Locations: Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital Phoenix, Arizona, United States

Arkansas Center for Bleeding Disorders Little Rock, Arkansas, United States

Orthopaedic Institute for Children HTC Los Angeles, California, United States

Childrens Hospital Los Angeles Los Angeles, California, United States

View all 76 locations

View Trial Details

Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07285460

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles, California, United States

The Center for Inherited Blood Disorders- Site Number : 8400009 Orange, California, United States

Cure 4 The Kids Foundation- Site Number : 8400001 Las Vegas, Nevada, United States

Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008 Hackensack, New Jersey, United States

View all 30 locations

View Trial Details

Recruiting

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

NCT07418099

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +12 more
Locations: Hospital Universitario Severo Ochoa Leganés, Madrid, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital Universitario Arnau De Vilanova Lleida, Spain

Hospital Universitario 12 de Octubre Madrid, Spain

View all 16 locations

View Trial Details

Recruiting

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

NCT07575308

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +21 more
Locations: Clinical Trial Site Miami, Florida, United States

Clinical Trial Site Los Angeles, California, United States

Clinical Trial Site Orange, California, United States

Clinical Trial Site Lexington, Kentucky, United States

View Trial Details

Recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

NCT05611801

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations: Arbesu Hematología Mendoza, Argentina

Murdoch Children's Research Institute Parkville, Australia

Medizinische Universität Wien Vienna, State of Vienna, Austria

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View all 64 locations

View Trial Details

Recruiting

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

NCT07220564

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: UC Denver Hemoph & Thrombo Ctr Aurora, Colorado, United States

Indiana Hemophilia-Thromb Ctr Indianapolis, Indiana, United States

University of Iowa_Iowa City Iowa City, Iowa, United States

Penn State MS Hershey Med Ctr Hershey, Pennsylvania, United States

View all 33 locations

View Trial Details

Recruiting

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: UC Davis Sacramento, California, United States

University of Florida Gainesville, Florida, United States

University of Minnesota Medical Center Minneapolis, Minnesota, United States

Washington University School of Medicine St Louis, Missouri, United States

View all 28 locations

View Trial Details

Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

NCT06003387

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: University of California, San Diego (UCSD) San Diego, California, United States

University of Michigan Ann Arbor, Michigan, United States

Hemophilia Center of Western Pennsylvania (HCWP) Pittsburgh, Pennsylvania, United States

Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

View all 31 locations

View Trial Details

Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

NCT07416526

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Nara Medical University Hospital Kashihara-shi, Nara, Japan

Tokyo Medical University Hospital Shinjuku-Ku, Tokyo, Japan

University of Colorado Hemophilia and Thrombosis Center Aurora, Colorado, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

View all 19 locations

View Trial Details

Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

NCT07416604

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Center for Inherited Blood Disorders Orange, California, United States

Innovative Hematology, Inc. Indianapolis, Indiana, United States

University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States

Washington Center for Bleeding Disorders Seattle, Washington, United States

View all 30 locations

View Trial Details

Coagulation Protein Disorders

Coagulation Protein Disorders trial results

Related conditions